Antihypertensive effect of nicardipine hydrochloride in essential hypertension. 1982

T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura

The antihypertensive effect of a new calcium antagonist, nicardipine hydrochloride (YC-93), was studied in 47 mild to moderate essential hypertensives. YC-93 (30-60 mg/day) was administered orally alone for 8 weeks (Group I, 31 patients) or in combination with diuretics, beta blockers, or both (Group II, 16 patients). Blood pressure was reduced from 173.6 +/- 2.2/103.5 +/- 1.7 to 139.7 +/- 2.0/87.2 +/- 1.1 mmHg in Group I and from 172.9 +/- 3.9/108.9 +/- 2.9 to 140.5 +/- 2.3/89.5 +/- 2.5 mm Hg in Group II. Pulse rate was not altered in Group I but increased transiently in Group II. The side effects seen in seven patients were mostly related to the vasodilatation and were generally transient and mild. These results indicate that YC-93 is an effective antihypertensive drug for the treatment of essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009529 Nicardipine A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. Antagonil,Cardene,Cardene I.V.,Cardene SR,Dagan,Flusemide,Lecibral,Lincil,Loxen,Lucenfal,Nicardipine Hydrochloride,Nicardipine LA,Nicardipino Ratiopharm,Nicardipino Seid,Perdipine,Ridene,Vasonase,Y-93,Hydrochloride, Nicardipine,LA, Nicardipine,Y 93,Y93
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females

Related Publications

T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
January 1985, British journal of clinical pharmacology,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
April 1986, Masui. The Japanese journal of anesthesiology,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
October 2017, Fundamental & clinical pharmacology,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
March 1983, Medicina clinica,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
April 1982, British journal of clinical pharmacology,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
July 1999, Cardiovascular drugs and therapy,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
February 1985, International journal of clinical pharmacology, therapy, and toxicology,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
January 1990, Progress in clinical and biological research,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
April 1995, Kyobu geka. The Japanese journal of thoracic surgery,
T Takabatake, and H Ohta, and Y Yamamoto, and M Maekawa, and S Arai, and N Hattori, and G Nomura
April 1989, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!